Sonoma Pharmaceuticals, Inc.·4

Jul 24, 6:54 PM ET

Miller Robert E 4

4 · Sonoma Pharmaceuticals, Inc. · Filed Jul 24, 2018

Insider Transaction Report

Form 4
Period: 2018-07-20
Miller Robert E
Chief Financial Officer
Transactions
  • Award

    Stock option (right to buy)

    2018-07-20+67,733209,071 total
    Exercise: $2.41From: 2018-07-20Exp: 2028-07-20Common Stock (67,733 underlying)
Footnotes (1)
  • [F1]The options were awarded and granted to Mr. Miller as a bonus for fiscal year 2018.

Documents

1 file
  • 4
    ownership.xmlPrimary